The global heparin coated stent market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from cardiovascular diseases and other chronic conditions such as diabetes mellitus, hypertension, and obesity. The increasing prevalence of these diseases has led to an increase in the number of procedures performed for treatment purposes. This has also led to an increase in the demand for heparin coated stents which are used as a preventive measure against blood clotting during surgery or angioplasty procedures.
The global heparin coated stent market by type is segmented into retrograde stents, antegrade stents, internal (double) stents and others (e.g., coronary artery bypass grafts). Retrograde stents are used for treating various types of vascular disorders such as peripheral arterial occlusive disease (PAOD), iliac artery stenosis, carotid artery stenosis and others; antegrade stents are used for treating coronary artery disease; internal (double) stents are used in ureteral lithotripsy procedures; while other types include coronary artery bypass grafts which are used in cardiac surgeries among others.
North America dominates the global heparin coated stent market with a share of over 40%. This can be attributed to factors such as high prevalence rates for chronic conditions like diabetes mellitus and hypertension among adults coupled with high healthcare expenditure per capita on medical devices like heparin coated implants which have been driving growth in this region's healthcare industry over recent years.
Some Of The Growth Factors Of This Market:
- The increasing number of patients with cardiovascular diseases is one of the major factors driving the growth of this market.
- Increasing prevalence of chronic diseases such as diabetes and obesity are also driving the growth in this market.
- Increasing awareness about cardiovascular diseases and its risk factors among people is also driving the growth in this market.
- Growing geriatric population base, which has higher incidence rates for cardiovascular disease, is another factor that will drive the growth in this market.
Industry Growth Insights published a new data on “Heparin Coated Stent Market”. The research report is titled “Heparin Coated Stent Market research by Types (Retrograde Stents, Antegrade Stents, Internal (double-J) Stents), By Applications (Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy), By Players/Companies Johnson & Johnson, Gore Medical, W.L. Gore, Medtronic”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Heparin Coated Stent Market Research Report
By Type
Retrograde Stents, Antegrade Stents, Internal (double-J) Stents
By Application
Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy
By Companies
Johnson & Johnson, Gore Medical, W.L. Gore, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Heparin Coated Stent Market Report Segments:
The global Heparin Coated Stent market is segmented on the basis of:
Types
Retrograde Stents, Antegrade Stents, Internal (double-J) Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Gore Medical
- W.L. Gore
- Medtronic
Highlights of The Heparin Coated Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Retrograde Stents
- Antegrade Stents
- Internal (double-J) Stents
- By Application:
- Lithotripsy
- Ureteroscopy
- Ureteroenoscopy
- Percutaneous Nephrolithotomy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Heparin Coated Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Heparin coated stents are a type of medical device that is inserted into the body to help support an artery. The device is made up of two parts: a metal frame and a plastic sheath. The metal frame holds the sheath in place while it's being inserted into the body, and then it releases the sheath once it's inside. Once inside, the sheath covers part of an artery so that blood can flow more easily through it.
Some of the major companies in the heparin coated stent market are Johnson & Johnson, Gore Medical, W.L. Gore, Medtronic.
The heparin coated stent market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Heparin Coated Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Heparin Coated Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Heparin Coated Stent Market - Supply Chain
4.5. Global Heparin Coated Stent Market Forecast
4.5.1. Heparin Coated Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Heparin Coated Stent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Heparin Coated Stent Market Absolute $ Opportunity
5. Global Heparin Coated Stent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Heparin Coated Stent Market Size and Volume Forecast by Type
5.3.1. Retrograde Stents
5.3.2. Antegrade Stents
5.3.3. Internal (double-J) Stents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Heparin Coated Stent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Heparin Coated Stent Market Size and Volume Forecast by Application
6.3.1. Lithotripsy
6.3.2. Ureteroscopy
6.3.3. Ureteroenoscopy
6.3.4. Percutaneous Nephrolithotomy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Heparin Coated Stent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Heparin Coated Stent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Heparin Coated Stent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Heparin Coated Stent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Heparin Coated Stent Demand Share Forecast, 2019-2026
9. North America Heparin Coated Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Heparin Coated Stent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Heparin Coated Stent Market Size and Volume Forecast by Application
9.4.1. Lithotripsy
9.4.2. Ureteroscopy
9.4.3. Ureteroenoscopy
9.4.4. Percutaneous Nephrolithotomy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Heparin Coated Stent Market Size and Volume Forecast by Type
9.7.1. Retrograde Stents
9.7.2. Antegrade Stents
9.7.3. Internal (double-J) Stents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Heparin Coated Stent Demand Share Forecast, 2019-2026
10. Latin America Heparin Coated Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Heparin Coated Stent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Heparin Coated Stent Market Size and Volume Forecast by Application
10.4.1. Lithotripsy
10.4.2. Ureteroscopy
10.4.3. Ureteroenoscopy
10.4.4. Percutaneous Nephrolithotomy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Heparin Coated Stent Market Size and Volume Forecast by Type
10.7.1. Retrograde Stents
10.7.2. Antegrade Stents
10.7.3. Internal (double-J) Stents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Heparin Coated Stent Demand Share Forecast, 2019-2026
11. Europe Heparin Coated Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Heparin Coated Stent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Heparin Coated Stent Market Size and Volume Forecast by Application
11.4.1. Lithotripsy
11.4.2. Ureteroscopy
11.4.3. Ureteroenoscopy
11.4.4. Percutaneous Nephrolithotomy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Heparin Coated Stent Market Size and Volume Forecast by Type
11.7.1. Retrograde Stents
11.7.2. Antegrade Stents
11.7.3. Internal (double-J) Stents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Heparin Coated Stent Demand Share, 2019-2026
12. Asia Pacific Heparin Coated Stent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Heparin Coated Stent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Heparin Coated Stent Market Size and Volume Forecast by Application
12.4.1. Lithotripsy
12.4.2. Ureteroscopy
12.4.3. Ureteroenoscopy
12.4.4. Percutaneous Nephrolithotomy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Heparin Coated Stent Market Size and Volume Forecast by Type
12.7.1. Retrograde Stents
12.7.2. Antegrade Stents
12.7.3. Internal (double-J) Stents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Heparin Coated Stent Demand Share, 2019-2026
13. Middle East & Africa Heparin Coated Stent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Heparin Coated Stent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Heparin Coated Stent Market Size and Volume Forecast by Application
13.4.1. Lithotripsy
13.4.2. Ureteroscopy
13.4.3. Ureteroenoscopy
13.4.4. Percutaneous Nephrolithotomy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Heparin Coated Stent Market Size and Volume Forecast by Type
13.7.1. Retrograde Stents
13.7.2. Antegrade Stents
13.7.3. Internal (double-J) Stents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Heparin Coated Stent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Heparin Coated Stent Market: Market Share Analysis
14.2. Heparin Coated Stent Distributors and Customers
14.3. Heparin Coated Stent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Gore Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. W.L. Gore
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medtronic
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
